
CHINA ASSOCIATE (GROUP) CO., LTD. is a Shenzhen-based diversified pharmaceutical group focused on R&D, manufacturing, and international trade, supported by a multi-subsidiary operating structure.
CHINA ASSOCIATE (GROUP) CO., LTD. was established in 1983 in Shenzhen and has grown into a large-scale, diversified enterprise spanning pharmaceutical R&D, manufacturing, and trading activities.
Across its group structure, the company’s subsidiaries focus on the production and marketing of bulk pharmaceutical products, pharmaceutical distribution and retail through chain drugstores, and import and export trading that also covers categories such as electronic products and textiles. The group is also active in property operations and management, including hospitality and commercial/industrial buildings.
Guided by a pragmatic, forward-looking culture emphasizing integrity and innovation, the company continues to strengthen capabilities and reputation while contributing to the development of healthcare.

Established in Shenzhen in 1983, the group operates as a diversified enterprise with a focus on pharmaceutical R&D, manufacturing, and trading, supported by a broad subsidiary network and long-term industry experience.
Subsidiaries are engaged in the manufacturing and marketing of bulk pharmaceutical products, supported by ongoing efforts to strengthen innovation and operational capabilities.
The group operates pharmaceutical commercial activities including chain drugstores and distribution services, with business links to multiple public hospitals and non-chain retail drugstores in Shenzhen.
The business includes import and export of pharmaceutical products, as well as trading activities covering electronic products, textiles, and other categories. The medical device and consumables business represents international brands and participates in public-sector and hospital tenders across multiple provinces.
The group also manages property operations, including restaurant, office building, and industrial building management, and operates a wholly owned hospitality business in Shenzhen’s Luohu commercial district.
Founded in 1988, this wholly owned subsidiary focuses on the R&D, production, sales, and after-sales service of medicines for the endocrine system.
The group invested in developing a production base in Pingshan, planned for completion in 2020, with facilities designed to meet GMP requirements for China, Europe, and the United States.
The group promotes standardized Chinese herbal materials and supports broader health services, working with production bases and partners to implement scientific, standardized practices from cultivation to circulation.
Send an enquiry to learn more about their capabilities and request custom quotes.